Related Experiment Video

Updated: Oct 25, 2025

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

11.8K

Clinical determinants of complete response to vismodegib in locally advanced basal cell carcinoma: a multicentre

M C Fargnoli1, C Pellegrini1, A Piccerillo2,3

  • 1Dermatology, Department of Biotechnological and Clinical Sciences, University of L'Aquila, L'Aquila, Italy.

Journal of the European Academy of Dermatology and Venereology : JEADV
|August 9, 2021
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.7K
Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
08:29

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics

Published on: October 2, 2014

14.9K

Related Experiment Videos

Last Updated: Oct 25, 2025

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

11.8K
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.7K
Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
08:29

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics

Published on: October 2, 2014

14.9K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.5K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K

Articles linked to this work by shared authors, journal, and citation graph.

The Role of General Practitioners in Actinic Keratosis Management in Europe: A Dermato-Oncologists Initiative.

Journal of clinical medicine·2026

The Cape Town Action Plan for Neglected Tropical Skin Diseases: From Workshop Consensus to Health-System Action.

International journal of dermatology·2026

LC-OCT for Cutaneous Lupus Erythematosus: Characterization Across Disease Subtypes and Differentiation From Rosacea.

Experimental dermatology·2026

Ruxolitinib cream in adults with moderate atopic dermatitis after failure of other topicals: A randomized trial.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Psoriasis treatments in Europe during the 19th century.

Dermatology reports·2026

In Vivo Microscopic Features of Acne vulgaris Revealed via LC-OCT.

Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)·2026

Targeted therapies in pemphigus vulgaris: Emerging horizons beyond rituximab.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Upcoming novel treatments for hidradenitis suppurativa: An overview of the pipeline.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Glucagon-like peptide-1 receptor agonists in hidradenitis suppurativa: A nationwide cohort study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Systemic pruritus as a neuroimmune disorder: Mechanistic insights and target-driven therapy.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

IADVL consensus recommendations on Trichophyton indotineae infections: Using modified Delphi method.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Psychiatric morbidity, genetic susceptibility and the risk of vitiligo.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us